CN109608392A - Stilbene class similar compound and its preparation method and application - Google Patents
Stilbene class similar compound and its preparation method and application Download PDFInfo
- Publication number
- CN109608392A CN109608392A CN201811534599.1A CN201811534599A CN109608392A CN 109608392 A CN109608392 A CN 109608392A CN 201811534599 A CN201811534599 A CN 201811534599A CN 109608392 A CN109608392 A CN 109608392A
- Authority
- CN
- China
- Prior art keywords
- compound
- similar compound
- stilbene class
- class similar
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 55
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960004705 kojic acid Drugs 0.000 claims abstract description 21
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 21
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 claims abstract description 14
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 7
- 150000004714 phosphonium salts Chemical group 0.000 claims abstract description 6
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 101710147108 Tyrosinase inhibitor Proteins 0.000 claims abstract description 4
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 150000001412 amines Chemical class 0.000 claims abstract description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 3
- 235000013305 food Nutrition 0.000 claims description 14
- 229940125904 compound 1 Drugs 0.000 claims description 6
- 229940125782 compound 2 Drugs 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 27
- 239000000243 solution Substances 0.000 description 31
- REDUQXCPUSNJOL-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(CN(C(C1=CC=C(C=C1)C(C)C)=O)CC1=CC=C(C=C1)C(NO)=O)=O Chemical compound C(C1=CC=CC=C1)NC(CN(C(C1=CC=C(C=C1)C(C)C)=O)CC1=CC=C(C=C1)C(NO)=O)=O REDUQXCPUSNJOL-UHFFFAOYSA-N 0.000 description 30
- 241000238557 Decapoda Species 0.000 description 30
- 102000003425 Tyrosinase Human genes 0.000 description 28
- 108060008724 Tyrosinase Proteins 0.000 description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 28
- 241000894006 Bacteria Species 0.000 description 26
- 238000012360 testing method Methods 0.000 description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 23
- 238000012545 processing Methods 0.000 description 23
- PHDIJLFSKNMCMI-ITGJKDDRSA-N (3R,4S,5R,6R)-6-(hydroxymethyl)-4-(8-quinolin-6-yloxyoctoxy)oxane-2,3,5-triol Chemical compound OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)OCCCCCCCCOC=1C=C2C=CC=NC2=CC=1)O PHDIJLFSKNMCMI-ITGJKDDRSA-N 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 230000002401 inhibitory effect Effects 0.000 description 20
- 238000000034 method Methods 0.000 description 19
- 239000000523 sample Substances 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 18
- 108090000790 Enzymes Proteins 0.000 description 18
- 238000005259 measurement Methods 0.000 description 16
- 230000005764 inhibitory process Effects 0.000 description 15
- 238000003860 storage Methods 0.000 description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 14
- 230000000844 anti-bacterial effect Effects 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 241000927735 Penaeus Species 0.000 description 11
- 239000003112 inhibitor Substances 0.000 description 11
- -1 4- hexyl Chemical group 0.000 description 10
- 235000015165 citric acid Nutrition 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- 239000012043 crude product Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- VFZRZRDOXPRTSC-UHFFFAOYSA-N 3,5-Dimethoxybenzaldehyde Chemical compound COC1=CC(OC)=CC(C=O)=C1 VFZRZRDOXPRTSC-UHFFFAOYSA-N 0.000 description 8
- MWDVCHRYCKXEBY-LBPRGKRZSA-N 3-chloro-n-[2-oxo-2-[[(1s)-1-phenylethyl]amino]ethyl]benzamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(Cl)=C1 MWDVCHRYCKXEBY-LBPRGKRZSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 241000739682 bacterium S1 Species 0.000 description 7
- 238000004321 preservation Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229940125898 compound 5 Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 4
- 229960005190 phenylalanine Drugs 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229960001755 resorcinol Drugs 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- LVHOHZHTZXRVRJ-CMDGGOBGSA-N (e)-3-(3-methoxyphenyl)-n-(3,4,5-trimethoxyphenyl)prop-2-enamide Chemical compound COC1=CC=CC(\C=C\C(=O)NC=2C=C(OC)C(OC)=C(OC)C=2)=C1 LVHOHZHTZXRVRJ-CMDGGOBGSA-N 0.000 description 3
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102000030523 Catechol oxidase Human genes 0.000 description 2
- 108010031396 Catechol oxidase Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241000863430 Shewanella Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000196253 Ulva prolifera Species 0.000 description 2
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 108010058393 monophenolase Proteins 0.000 description 2
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- VPMIAOSOTOODMY-KJAPKAAFSA-N (4r)-6-[(e)-2-[6-tert-butyl-4-(4-fluorophenyl)-2-propan-2-ylpyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one Chemical compound C([C@H](O)C1)C(=O)OC1/C=C/C=1C(C(C)C)=NC(C(C)(C)C)=CC=1C1=CC=C(F)C=C1 VPMIAOSOTOODMY-KJAPKAAFSA-N 0.000 description 1
- QRDAPCMJAOQZSU-KQQUZDAGSA-N (e)-3-[4-[(e)-3-(3-fluorophenyl)-3-oxoprop-1-enyl]-1-methylpyrrol-2-yl]-n-hydroxyprop-2-enamide Chemical compound C1=C(\C=C\C(=O)NO)N(C)C=C1\C=C\C(=O)C1=CC=CC(F)=C1 QRDAPCMJAOQZSU-KQQUZDAGSA-N 0.000 description 1
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- CYSWUSAYJNCAKA-FYJFLYSWSA-N ClC1=C(C=CC=2N=C(SC=21)OCC)OC1=CC=C(C=N1)/C=C/[C@H](C)NC(C)=O Chemical compound ClC1=C(C=CC=2N=C(SC=21)OCC)OC1=CC=C(C=N1)/C=C/[C@H](C)NC(C)=O CYSWUSAYJNCAKA-FYJFLYSWSA-N 0.000 description 1
- QBXVXKRWOVBUDB-GRKNLSHJSA-N ClC=1C(=CC(=C(CN2[C@H](C[C@H](C2)O)C(=O)O)C1)OCC1=CC(=CC=C1)C#N)OCC1=C(C(=CC=C1)C1=CC2=C(OCCO2)C=C1)C Chemical compound ClC=1C(=CC(=C(CN2[C@H](C[C@H](C2)O)C(=O)O)C1)OCC1=CC(=CC=C1)C#N)OCC1=C(C(=CC=C1)C1=CC2=C(OCCO2)C=C1)C QBXVXKRWOVBUDB-GRKNLSHJSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 244000174681 Michelia champaca Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241000264279 Sargassum fusiforme Species 0.000 description 1
- 241000865982 Shewanella amazonensis Species 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- SRVFFFJZQVENJC-IHRRRGAJSA-N aloxistatin Chemical compound CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C SRVFFFJZQVENJC-IHRRRGAJSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- KSCRVOKQPYZBHZ-IXPOFIJOSA-N benzyl n-[(2s)-1-[[(2s)-1-[[(2s)-1-(1,3-benzothiazol-2-yl)-1-oxo-3-[(3s)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@H]1C(NCC1)=O)C(=O)C=1SC2=CC=CC=C2N=1)C(C)C)C(=O)OCC1=CC=CC=C1 KSCRVOKQPYZBHZ-IXPOFIJOSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- YKYMGFHOJJOSEB-UHFFFAOYSA-N butan-1-ol;potassium Chemical compound [K].CCCCO YKYMGFHOJJOSEB-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- QAPTWHXHEYAIKG-RCOXNQKVSA-N n-[(1r,2s,5r)-5-(tert-butylamino)-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 QAPTWHXHEYAIKG-RCOXNQKVSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019465 surimi Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B4/00—General methods for preserving meat, sausages, fish or fish products
- A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
- A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
- A23B4/20—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses stilbene class similar compound, general structure is following any:The present invention further simultaneously discloses the preparation method of above-mentioned stilbene class similar compound: using kojic acid as raw material, reacting to obtain quaternary phosphonium salt with triphenylphosphine after benzyl protection, chlorination;Quaternary phosphonium salt occurs wittig with benzaldehyde and reacts;Reaction gains are deprotected through Boron tribromide or reaction gains are reacted with the fatty amine of different carbon chain lengths and are deprotected again through Boron tribromide, obtain stilbene class similar compound.Stilbene class similar compound can serve as tyrosinase inhibitor, antibacterial agent, antioxidant etc..
Description
Technical field
The present invention relates to a kind of agent for preservation of shrimp and its preparation method with stilbene class similar structures, the stilbene class similar compounds
With tyrosinase inhibitory activity, antibacterial and the multiple biological activities such as anti-oxidant.
Background technique
Shrimps are a kind of high-moisture protein foods, are after death highly prone to the influence of the factors such as polyphenol oxidase, bacterium and send out
Raw blacking and putrid and deteriorated.Polyphenol oxidase (PPO) such as tyrosinase in shrimp body is after death activated in shrimp, in aerobic conditions
Under, single phenol substance contained in shrimps is oxidized to bisphenol by tyrosinase catalysis, and then is catalyzed and generates coloured quinone
Then substance occurs a series of biochemical reactions and generates melanin, to cause the blacking of shrimp body.After shrimp body is dead, newly
Protein, amino acid and other nitrogen substances in fresh shrimp, are easily decomposed into a variety of nitrogen-containing basics under the action of bacterium
Product, and niff is generated, such as hydrogen sulfide, bad smell.Xi Washi spoilage organisms is advantage corruption common in aquatic products
Bacterium can quickly breed after shrimp body is dead, have the rotten ability of extremely strong cause.In addition, protein, how unsaturated rouge in shrimps
Oxidation deterioration easily occurs for the substances such as fat acid, while generating a large amount of free radicals, highly unstable, the chemical reaction with height
Property, it is easy to it reacts with other molecules, and then generates more free radicals, further promote the rotten of shrimp.
Current existing agent for preservation of shrimp is numerous, multi-pass cross inhibit tyrosinase activity, antibacterial or antioxidation reach
To preservation, such as 4- hexyl resorcin, arbutin tyrosinase inhibitor, the bacteriostatic agents such as ε polylysine, chitosan,
The antioxidants such as resveratrol, ascorbic acid.But most antistaling agents only have single creature activity, and its fresh-keeping application is by certainly
The limitation of body defect, such as price it is higher, be more toxic.Therefore, it is obtained by research and safe and efficient, cheap has anti-junket
The antistaling agent of the multiple biological activities such as propylhomoserin enzyme, antibacterial is the work with huge meaning and value.
There is stronger tyrosinase to inhibit to live for kojic acid, entitled 5- hydroxyl -2- (methylol) -4 hydrogen-pyrans -4- ketone of chemistry
The multiple biological activities such as property, antioxidant activity, are not only applicable in skin-lightening cosmetic, used also as food additives.Therefore,
It is to obtain an important way of high activity food preservative, bacteriostatic agent and antioxidant by the structural modification to kojic acid molecule
Diameter.
The structural formula with the compound compared with strong biological activity obtained by kojic acid molecular modification existing at present are as follows:
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of stilbene class similar compound and preparation method thereof, such compounds
With good tyrosinase inhibitory activity, antibacterial activity and antioxidant activity;It can be used for the fresh-keeping of food in the food industry,
It can be used as antibacterial agent in field of medicaments, be alternatively arranged as whitening agent for cosmetics industry.
In order to solve the above technical problem, the present invention provides a kind of stilbene class similar compounds (to have antityrosinase, antioxygen
Change the stilbene class similar compound with multiple biological activities such as antibacterials), general structure is following general formula 1,2:
R in compound1Respectively 4-OH, 3,4-di-OH, 3,5-di-OH, R2For CnH2n+1(n=1-12).
As the improvement of stilbene class similar compound of the invention, structural formula be it is following any one:
The present invention also and meanwhile provide the preparation method of above compound, successively the following steps are included:
1), using kojic acid as raw material, react after benzyl protection, chlorination with triphenylphosphine quaternary phosphonium salt (that is, compound
6);
2), quaternary phosphonium salt is reacted with benzaldehyde generation Wittig;
3), step 2) gains (that is, compound 7) are deprotected through Boron tribromide, and it is similar to obtain the stilbene class containing free hydroxyl group
Compound 1;
Alternatively, step 2) gains (that is, compound 7) are reacted with the fatty amine of different carbon chain lengths, then through Boron tribromide
The stilbene class similar compound 2 for being deprotected containing free hydroxyl group.
The present invention also simultaneously provide the purposes of above-mentioned stilbene class similar compound: as tyrosinase inhibitor, antibacterial agent,
Antioxidant, the fresh-keeping or cosmetics for food.
The usage and dosage of stilbene class similar compound of the invention are identical as kojic acid.
Stilbene class similar compound of the invention is better than kojic acid to the preservation of shrimps.
Detailed description of the invention
Specific embodiments of the present invention will be described in further detail with reference to the accompanying drawing.
Fig. 1 is inhibiting effect comparison diagram of the compound 1c and 2h to diphenolase;
Fig. 2 is influence diagram of the compound 1c and 2h to bacterium S1 growth curve;
Fig. 3 is that compound 2h and citric acid cooperate with bacteriostasis figure;Concentration of the compound 2h in I-III group is respectively
10,20,40 μ g/mL, the concentration of citric acid are 50 μ g/mL.
Fig. 4 is Penaeus Vannmei L during 4 DEG C of storages*(A), a*(B), b*(C) variation diagram;
Fig. 5 is the variation diagram of Penaeus Vannmei Volatile Base Nitrogen (TVB-N) during 4 DEG C of storages;
Fig. 6 is the variation diagram of Penaeus Vannmei total number of bacteria during 4 DEG C of storages.
Specific embodiment
The present invention is described further combined with specific embodiments below, but protection scope of the present invention is not limited in
This:
With kojic acid (3) be Material synthesis compound 1 (a-c) and the route of 2 (a-i) is as shown in Scheme1.
The preparation method of embodiment 1-1, compound 1c successively carry out following steps:
The synthesis of compound 4 is to be raw material with kojic acid (3) and synthesize (Design and by literature procedure
synthesis of hydroxypyridinone-L-phenylalanine conjugates as potential
tyrosinase inhibitors.Journal of Agricultural and Food Chemistry 2013,61(27),
6597-6603)。
Compound 4:5- benzyloxy -2- methylol-pyrans -4- ketone, yield 82.7%.1H NMR(400MHz,DMSO-d6,δ
Ppm) δ: 4.30 (d, J=6.0Hz, 2H, CH2),4.96(s,2H,CH2), 5.67 (t, J=6.0Hz, 1H, OH), 6.34 (s, 1H,
), Py-H 7.34-7.44 (m, 5H, Ar-H), 8.17 (s, 1H, Py-H) .ESI-HRMS:m/z, calculated value C13H13O4([M+H]+)
233.0808 measured value 233.0830.
A, the synthesis of compound 5
It weighs 30g (129.72mmol) compound 4 (5- benzyloxy -2- methylol-pyrans -4- ketone) and is dissolved in 100mL chlorination
In sulfoxide, in room temperature reaction 2h, after reaction, filters, obtain pale yellow precipitate, room temperature is dry after being washed with acetone (about 100mL)
It is dry to constant weight, obtain white solid -- compound 5.Yield is 72.5%.
Compound 5:5- benzyloxy -2- chloromethyl-pyrans -4- ketone, yield 72.5%.1H NMR(400MHz,DMSO)δ:
4.68(s,2H,CH2),4.96(s,2H,CH2),6.58(s,1H,Py-H),7.38(m,5H,Ar-H),8.30(s,1H,Py-H)
.ESI-HRMS:m/z, calculated value C13H12ClO3([M+H]+) 251.0469, measured value 251.0480.
B, the synthesis of compound 6
20g (79.9mmol) compound 5 is weighed respectively and 20g (79.9mmol) triphenylphosphine is added to equipped with 150mL first
In the round-bottomed flask of benzene, the monitoring of heating reflux reaction 12h, TLC contact plate.A large amount of white precipitates are generated in reaction process, after suction filtration
It is washed with paraxylene (about 100mL), drying at room temperature to constant weight, obtains white compound crude product (that is, 6 crude product of compound)
28.64g is not purified and is directly used in the next step.
C, the synthesis of compound 7c
It weighs 6 crude product of 3.078g (6mmol) compound to be added into 10mLDMF, uncle 0.808g is added under nitrogen protection
Butanol potassium, is stirred at room temperature 30min.1.097g 3,5- dimethoxy benzaldehyde, in 70 DEG C of reaction 7h is added.It passes through after reaction
Silica gel column chromatography obtains compound 7c, yield 78.6%.
The specific steps of compound 7c crude product silica gel column chromatography purifying are as follows: with petrol ether/ethyl acetate (volume ratio of 4:1)
As eluent;Collect Rf=0.45 solution, boils off solvent, obtains sterling 7c.
The structural formula of 7c are as follows:
5- benzyloxy -2- (2 (3,5- dimethoxy-phenylf)-vinyl)-pyrans -4- ketone (7c): yield 78.6%.1H
NMR(500MHz,CDCl3,δppm)δ:3.84(s,6H,2OCH3),5.10(s,2H,CH2),6.40(s,1H,Py-H),6.48
(s, 1H, Ar-H), 6.63 (d, J=16.5Hz, 1H, CH=CH), 6.64 (d, J=1.0Hz, 2H, Ar-H), 7.26 (d, J=
16.5Hz, 1H, CH=CH), 7.38 (m, 5H, Ar-H), 7.55 (s, 1H, Py-H) .ESI-HRMS:m/z, calculated value C22H21O5
([M+H]+) 365.1384, measured value 365.1377.
D, the synthesis of compound 1c
It weighs 0.364g (1mmol) compound 7c to be dissolved in the three-neck flask equipped with 10mL methylene chloride, connection nitrogen dress
It sets, makes reaction system full of nitrogen.Under the conditions of 0 DEG C, 10mL is slowly added dropwise using constant pressure funnel and contains 1mmol/mL tri-
The dichloromethane solution (time for adding is about 10~12 minutes) of boron bromide, is then gradually warmed up (heating-up time is about 2 hours)
To room temperature, react overnight (12h).Appropriate methanol (about 10mL) is slowly added dropwise after reaction is completely dissolved precipitating, then revolves
Solvent (that is, removing methylene chloride, methanol) is evaporated off, with methanol ether (methanol: ether=1:2 volume ratio) recrystallization three
It is secondary, obtain compound 1c, yield 92.6%.
5- hydroxyl -2- [2- (3,5- dihydroxy-phenyl)-vinyl]-pyrans -4- ketone (1c) yield 92.6%.1H NMR
(400MHz,DMSO-d6, δ ppm) and δ: 6.50 (m, 2H, Ar-H), 6.54 (s, 1H, Py-H), 6.69 (d, J=2.8Hz, 1H, Ar-
H) 6.93 (d, J=16.4Hz, 1H, CH=CH), 7.56 (d, J=16.4Hz, 1H, CH=CH), 8.10 (s, 1H, Py-H)13C
NMR(100MHz,CD3OD,δppm)102.43,104.88,105.36,113.37,122.99,133.56,136.16,
139.91,146.35,155.75,157.67,160.83,174.55.ESI-HRMS:m/z calculated value C13H11O4([M+H]+)
247.0601 measured value 247.0611.
Embodiment 1-2,
3,5- dimethoxy benzaldehyde in embodiment 1-1 step C is changed to 4-methoxybenzaldehyde, 3,4- diformazan respectively
Oxygroup benzaldehyde, remaining is equal to embodiment 1-1;To obtain compound 1a, 1b accordingly.
The structural formula of compound 1a are as follows:
The structural formula of compound 1b are as follows:
The preparation method of embodiment 2, compound 2h successively carries out following steps:
The synthesis of compound 4 is to be raw material with kojic acid (3) and synthesize (Design and by literature procedure
synthesis of hydroxypyridinone-L-phenylalanine conjugates as potential
tyrosinase inhibitors.Journal of Agricultural and Food Chemistry 2013,61(27),
6597-6603)。
Compound 4:5- benzyloxy -2- methylol-pyrans -4- ketone: yield 82.7%.1H NMR(400MHz,DMSO-d6,δ
Ppm) δ: 4.30 (d, J=6.0Hz, 2H, CH2),4.96(s,2H,CH2), 5.67 (t, J=6.0Hz, 1H, OH), 6.34 (s, 1H,
), Py-H 7.34-7.44 (m, 5H, Ar-H), 8.17 (s, 1H, Py-H) .ESI-HRMS:m/z, calculated value C13H13O4([M+H]+)
233.0808 measured value 233.0830.
A, the synthesis of compound 5
It weighs 30g (129.72mmol) compound 4 (5- benzyloxy -2- methylol-pyrans -4- ketone) and is dissolved in 100mL chlorination
In sulfoxide, in room temperature reaction 2h, a large amount of pale yellow precipitates are filtered to obtain after reaction, after being washed with a large amount of acetone (100mL)
White solid -- compound 5, yield 72.5%.
Compound 5:5- benzyloxy -2- chloromethyl-pyrans -4- ketone (4): yield 72.5%.1H NMR(400MHz,DMSO)
δ:4.68(s,2H,CH2),4.96(s,2H,CH2),6.58(s,1H,Py-H),7.38(m,5H,Ar-H),8.30(s,1H,Py-
H) .ESI-HRMS:m/z, calculated value C13H12ClO3([M+H]+) 251.0469, measured value 251.0480.
B, the synthesis of compound 6
20g (79.9mmol) compound 5 is weighed respectively and 20g (79.9mmol) triphenylphosphine is added to equipped with 150mL first
In the round-bottomed flask of benzene, the monitoring of heating reflux reaction 12h, TLC contact plate.A large amount of white precipitates are generated in reaction process, after suction filtration
It is washed with paraxylene (about 100mL), drying at room temperature obtains white compound crude product (that is, 6 crude product of compound) 28.64g, does not purify
It is directly used in the next step.
C, the synthesis of compound 7c
It weighs 6 crude product of 3.078g (about 6mmol) compound to be added into 10mL DMF, 0.808g is added under nitrogen protection
30min is stirred at room temperature in potassium tert-butoxide.1.097g 3,5- dimethoxy benzaldehyde, in 70 DEG C of reaction 7h is added.After reaction
Compound 7c, yield 78.6% are obtained through silica gel column chromatography.
The specific steps that compound 7c crude product silica gel column chromatography is purified are as follows: with the petrol ether/ethyl acetate (volume of 4:1
Than) it is used as eluent;Collect Rf=0.45 solution boils off solvent and obtains sterling 7c.
The structural formula of 7c are as follows:
5- benzyloxy -2- [2 (3,5- dimethoxy-phenylf)-vinyl]-pyrans -4- ketone (7c): yield 78.6%.1H
NMR(500MHz,CDCl3,δppm)δ:3.84(s,6H,2OCH3),5.10(s,2H,CH2),6.40(s,1H,Py-H),6.48
(s, 1H, Ar-H), 6.63 (d, J=16.5Hz, 1H, CH=CH), 6.64 (d, J1=1.0Hz, 2H, Ar-H), 7.26 (d, J=
16.5Hz, 1H, CH=CH), 7.38 (m, 5H, Ar-H), 7.55 (s, 1H, Py-H) .ESI-HRMS:m/z, calculated value C22H21O5
([M+H]+) 365.1384, measured value 365.1377.
D, the synthesis of compound 8h
It weighs 1.82g (5mmol) compound 7c and (ethyl alcohol: water=1:1) is added into 20mL ethanol water, add 1g
Sodium hydroxide and 0.56g (5.5mmol) n-hexylamine, are condensed back 8h, and TLC monitors reaction process.After reaction, big portion is boiled off
Divide solvent (that is, most of ethyl alcohol, water being boiled off, until about the 30% of original volume), resulting reaction solution is extracted with dichloromethane 3
It is secondary, merge organic layer, through saturated common salt water washing 2-3 times, boils off solvent after crossing anhydrous sodium sulfate, obtain chemical combination through silica gel column chromatography
Object 8h, yield 40.8%.
The specific steps of compound 8h crude product silica gel column chromatography purifying are as follows: with methylene chloride/methanol (volume ratio of 50:1)
As eluent;Collect Rf=0.42 solution boils off solvent and obtains sterling 8h.
The structural formula of 8h are as follows:
5- benzyloxy -2- [2 (3,5- dimethoxy-phenylf)-vinyl] -1- hexyl-pyridine -4- ketone (8h): yield
40.8%.1H NMR(500MHz,CDCl3, δ ppm) and δ: 0.87 (t, J=5.5Hz, 3H, CH3),1.23(m,6H,3CH2),1.62
(m,2H,CH2), 3.78 (t, J=6.5Hz, 2H, CH2),3.85(s,6H,2OCH3),5.24(s,2H,CH2), 6.49 (t, J=
1.5Hz, H, Ar-H), 6.62 (d, J=2.0Hz, 2H, Ar-H), 6.70 (s, 1H, Py-H), 6.82 (d, J=16.0Hz, 1H, CH
=CH), 6.92 (s, 1H, Py-H), 7.02 (d, J=16.0Hz, 1H, CH=CH), 7.38 (m, 6H, Ar-H) .ESI-HRMS:m/
Z, calculated value C28H34NO4([M+H]+) 448.2482, measured value 448.2495.
E, the synthesis of compound 2h
It weighs 0.447g (1mmol) compound 8h to be dissolved in the three-neck flask equipped with 10mL methylene chloride, connection nitrogen dress
It sets, makes reaction system full of nitrogen.Under the conditions of 0 DEG C, 10mL is slowly added dropwise using constant pressure funnel and contains 1mmol/mL tri-
The dichloromethane solution (time for adding is about 10~12 minutes) of boron bromide, is then gradually warmed up (heating-up time is about 2 hours)
To room temperature, react overnight (12h).Appropriate methanol (10mL) is slowly added dropwise after reaction is completely dissolved precipitating, then rotates
Solvent (that is, removing methylene chloride, methanol) is removed, three times with methanol ether (methanol: ether=1:2 volume ratio) recrystallization,
Obtain compound 2h, yield 95.6%.
5- hydroxyl -2- [2 (3,5- dihydroxy-phenyl)-vinyl] -1- hexyl-pyridine -4- ketone (2h): yield 95.6%
.1H NMR(500MHz,CD3OD, δ ppm) δ: 0.91 (t, J=7.5Hz, 3H, CH3),1.36(m,6H,3CH2),1.85(m,2H,
CH2), 4.47 (t, J=7.5Hz, 2H, CH2), 6.34 (s, 1H, Ar-H), 6.62 (d, J=2.0Hz, 2H, Ar-H), 7.20 (d, J
=16.0Hz, 1H, CH=CH), 7.32 (d, J=16.0Hz, 1H, CH=CH), 7.43 (s, 1H, Py-H), 8.12 (s, 1H, Py-
H).13C NMR(125MHz,CD3OD,δppm)12.87,22.10,25.47,29.93,30.89,56.26,104.23,
105.90,110.35,116.64,130.77,136.71,140.60,144.82,146.39,159.69,160.00.ESI-
HRMS:m/z, calculated value C19H24NO4([M+H]+) 330.1700, measured value 330.1713.
Embodiment 2-2,
3,5- dimethoxy benzaldehyde in embodiment 2-1 step C is changed to 4-methoxybenzaldehyde or 3,4- bis- respectively
N-hexylamine in step D is changed to n-butylamine or n-octyl amine by methoxybenzaldehyde respectively, remaining is equal to embodiment 2-1;To
It is corresponding to obtain compound 2a, 2b, 2c, 2d, 2e, 2f, 2g, 2i.
The structural formula of compound 2a are as follows:
The structural formula of compound 2b are as follows:
The structural formula of compound 2c are as follows:
The structural formula of compound 2d are as follows:
The structural formula of compound 2e are as follows:
The structural formula of compound 2f are as follows:
The structural formula of compound 2g are as follows:
The structural formula of compound 2i are as follows:
Experiment 1, the measurement of compound 1 and 2 pair Mushroom Tyrosinase single phenol enzyme inhibition activity
Tyrosinase single phenol enzyme activity determination bibliography (Design and synthesis of
hydroxypyridinone-L-phenylalanine conjugates as potential tyrosinase
inhibitors.Journal of Agricultural and Food Chemistry 2013,61(27),6597-6603)
Method and slightly improve: tyrosinase single phenol enzyme activity determination is with 2mMLTyrosine is substrate, and total live body system is 300 μ
L is separately added into (30 DEG C of substrate solution of 100 μ L 2mM in the phosphate buffer (PBS (pH 6.86)) that 180 μ L are prepared in advance
Heat preservation) and a series of 10 various concentrations of μ L compound 1 or 2 solution (0.0313-1.0mM is previously dissolved in DMSO), finally it is fast
10 μ L Mushroom Tyrosinase solution (enzyme activity 500u/mL) are added in speed, and 30 DEG C of guarantors in constant incubator are transferred quickly to after mixing
Warm 10min measures absorbance value at 475nm.Solution needed for testing follows ready-to-use principle, tests parallel 3 times and makes even
Mean value.The composition of the reaction system of difference group is specifically such as table 1.
1 reaction solution system of table
Compound calculates the active inhibiting rate of tyrosinase monophenolase as follows:
Inhibiting rate (%)=[1- (OD3-OD4)/(OD1-OD2)] × 100%
Wherein OD1、OD2、OD3And OD4The absorbance value of respectively first to the 4th group of solution.
Compound increases, single phenol enzyme activity the active inhibiting effect of tyrosinase monophenolase with the increase of compound concentration
Property inhibiting rate be 50% when compound concentration (IC50) it is shown in Table 2.The single phenol enzyme inhibition activity of compound 1c and 2h are most strong, respectively
It is 8.03 and 4.60 times of kojic acid.
The tyrosinase inhibitory activity of 2 compound 1 and 2 of table
It chooses the preferable compound 1c and 2h of tyrosinase single phenol enzyme inhibition activity and measures it to tyrosinase diphenolase
Inhibitory activity (experiment 2) inhibits type and inhibition constant (experiment 3).
Test 2, measurement of the compound 1c and 2h to Mushroom Tyrosinase diphenol enzyme inhibition activity
Diphenol enzyme activity determination bibliography (Design and synthesis of hydroxypyridinone-L-
phenylalanine conjugates as potential tyrosinase inhibitors.Journal of
Agricultural and Food Chemistry 2013,61 (27), 6597-6603) method: tyrosinase diphenol enzyme activity
Power measurement is with 0.5mMLDOPA is substrate, and total live body system is 300 μ L, in the phosphate buffer that 180 μ L are prepared in advance
The change of substrate solution (the 30 DEG C of heat preservations) and a series of 10 various concentrations of μ L of 100 μ L 2mM is separately added into (PBS (pH 6.86))
It closes object 1c or 2h solution (0.0313-1.0mM is previously dissolved in DMSO), is eventually adding 10 μ L Mushroom Tyrosinase solution (enzyme activity
It for 500u/mL), mixes rapidly, the reaction system change of absorbance value at any time at 475nm is detected under 30 DEG C of constant temperatures
Change, determining instrument is the full-automatic microplate reader of Infinite M200.It is plotted against time with absorbance value, the straight line portion of curve obtained
The slope divided is enzyme activity, is mapped with the relative surplus vigor of enzyme to inhibitor concentration, and the relative surplus vigor of enzyme is 50%
When corresponding inhibitor concentration be inhibitor rate IC half-suppressed50.Acquired results are as shown in Figure 1.
The relative activity of enzyme reduces to some extent with the increase of compound 1c or 2h concentration, illustrates that 1c or 2h are inhibited
The vigor of tyrosinase diphenolase, and concentration is bigger, rejection ability is stronger.Suppression of the compound 1c to tyrosinase o-diphenolase activity
Concentration (the IC of compound when rate processed is 50%50) be 7.15 μm of ol/L, 2h concentration (IC50) it is 15.86 μm of ol/L;Through than
Relatively know that 1c is better than 2h to the rejection ability of diphenolase.Concentration (the IC of existing pyridone ketone derivatives 9a, 9b, 9c50) respectively
For 4.00,8.97,26.20 μm of ol/L.
Experiment 3,1c and 2h inhibit the measurement of type and inhibition constant to tyrosinase diphenolase
Measuring method and 2 measuring methods of experiment are essentially identical, and the concentration of fixed tyrosinase changes additionLDOPA
Amount measures influence of the various concentration 1c or 2h to enzyme activity.It is dense with substrate using the bis- counting backward technique mappings of Lineweaver-Burk
The inverse 1/ [S] of degree is X-axis, using 1/ υ of inverse of reaction speed as Y-axis, to judge the inhibition type of inhibitor.With the oblique of straight line
Rate and the intercept in Y-axis map again to inhibitor concentration, find out inhibitor to the inhibition constant K of resolvase (E)IWith it is right
The inhibition constant K of enzyme-substrate complex (ES)IS。
With the increase of 1c and 2h concentration, not only make the maximum reaction velocity (V of enzymatic reactionmax) become smaller, also result in Michaelis
Constant (Km) become larger, it is known that 1c and 2h is mixed type to the inhibition type of tyrosinase diphenolase.Compound 1c and 2h is to junket ammonia
Sour enzyme diphenolase inhibits type and inhibition constant to be shown in Table 3.
The tyrosinase diphenolase of table 3 compound 1c and 2h inhibit type and inhibition constant
Test the Determination of Antibacterial Activity of 4, compound 1c and 2h
It is raw by measurement antibacterial circle diameter size, minimal inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and bacterium
Long curve experiments research compound 1c and 2h is for being isolated from the dominant spoilage organisms genus Shewanella S1 of Penaeus Vannmei
The antibacterial activity of (Shewanella amazonensis).And compound 2h and citric acid are studied for the Synergistic antimicrobial of bacterium S1
Effect.
The preparation of bacteria suspension: the freezing for being stored in -80 DEG C is taken out for examination strain and is thawed in room temperature.Use liquid-transfering gun
(pipette tips sterilizing) is drawn 200 μ L bacterium solutions and is added separately in sterilized 50mL pancreas peptone soybean broth, 30 DEG C, 180r/min
Constant-temperature table culture 18-24h.A small amount of bacteria suspension is dipped in solid agar medium table after sterilization and cooling with aseptic inoculation ring
Face scribing line, has single colonie generation after guaranteeing culture.Inoculated solid medium is placed in 30 DEG C of constant incubators
Cultivate 16-18h.With the good single colonie secondary inoculation of aseptic inoculation ring picking thalli morphology into soybean broth, again in 30
DEG C, 180r/min constant-temperature table culture 18-24h.Activated bacterium solution is subjected to 10 times of gradient method dilutions, until reaching most suitable
It is spare to be placed in 4 DEG C of refrigerators for growth concentration.
1, minimal inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) measurement
After minimal inhibitory concentration (MIC) refers in vitro culture bacterium 18-24h, it is able to suppress the minimum drug of bacterial growth
Concentration, for measuring bacterium for the sensitivity of drug.The specific method is as follows: pipetting 900 μ L using liquid-transfering gun and has sterilized greatly
A series of compound solution (the compound 1c of 80 various concentrations of μ L is then added into teat glass (13 × 100mm) in beans meat soup
And the final concentration of 0-1mg/mL of 2h, the final concentration of 0-4mg/mL of kojic acid), being subsequently added into 20 μ L bacteria suspensions, (bacterial concentration is
105CFU/mL), so that mixed solution final volume is 1mL, rock mixing and be placed in 30 DEG C of constant incubators and cultivate for 24 hours.Culture
After detect by an unaided eye, it is minimal inhibitory concentration (MIC) that sample solution final concentration representated by muddy test tube does not occur, often
Group test is parallel three times.
Do not occur to move respectively in muddy test tube (sample solution final concentration >=MIC) from minimal inhibitory concentration (MIC) test
Take 100 μ L solution coatings on solid medium, constant temperature incubation observes on culture medium whether have bacterium colony for 24 hours afterwards under the conditions of 30 DEG C
Growth.If there is bacterium colony is grown, illustrate still there is bacteria living in corresponding MIC test tube, if sterile length of being born on culture medium,
Then compound solution final concentration representated by this test tube is minimum bactericidal concentration (MBC), and every group of test is in parallel three times.
Minimal inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) test result are shown in Table 4.
Minimal inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 4 compound of table to S1 bacterial strain
2, inhibition zone test (filter paper agar diffusion method)
This test is using filter paper agar diffusion method test compound 1c and 2h for the inhibiting effect of bacterium S1.Specific side
Method is as follows:
(1) filter paper is broken into the circular filter paper piece that diameter is 6mm with punch, is dried for standby after sterilizing.
(2) certain initial concentration solution is prepared according to test requirements document, carries out gradient dilution, wherein compound 1c and 2h concentration
For 10,20,40mg/mL, kojic acid 10,20,40,80mg/mL.It is molten that filter paper after sterilizing is soaked in various concentration compound
In liquid, drying is placed in spare under aseptic condition after immersion 2h.To be soaked in the filter paper of sterile water as blank control.
(3) drawing 1mL concentration is 105CFU/mL bacteria suspension sterilizes to 20mL and is cooled to 50 DEG C of solid agar medium
In, it is poured into immediately into plate after mixing, to its cooled and solidified under aseptic condition.
(4) it with the susceptibility filter paper of tweezers clamping various concentration, is put down gently on corresponding solid agar medium, gently
Light press filter paper is bonded it completely with culture medium.Test uses 4 methods, i.e., places 4 small filter paper dicks in each plate,
Respectively test-compound 1c and 2h, kojic acid (positive control) and sterile water (negative control).Then each group plate is placed in
It is cultivated in 30 DEG C of constant incubators for 24 hours, using vernier caliper measurement antibacterial circle diameter, each processing is parallel three times.Test result
It is shown in Table 5.
Inhibition zone test result of 5 compound of table to S1 bacterial strain
By table 4, table 5 it is found that 1c and 2h is obviously stronger than that kojic acid to the inhibiting effect of genus Shewanella bacterium S1.
3, to the influence of growth curve of bacteria
It takes a certain amount of test bacterium solution in the sterile soy broth of 50mL, is separately added into the compound of 1mL 5mg/mL
1c and 2h, makes its final concentration of 100 μ g/mL after mixing, 30 DEG C, 180r/min shaking table culture measured bacteria suspension every 2 hours
OD600Value, with incubation time (hour) for abscissa, OD600Value is ordinate, the growth curve of bacterium S1 is drawn, not add
The bacteria suspension of compound is as blank control.
From Figure 2 it can be seen that the absorbance value of 1c processing group is significantly less than blank control group each culture period (removing 0h),
Illustrate that compound 1c has stronger inhibiting effect for bacterium S1.In addition, the bacterium of 2h processing group in entire culture period not
There is apparent OD value variation, also do not occur logarithmic phase, illustrates that concentration is that the compound 2h of 100 μ g/mL has been completely inhibited
The growth of bacterium S1.
4, bacteriostatic test is cooperateed with
270 μ L are pipetted with liquid-transfering gun and have sterilized soybean broth into the 96 clean orifice plates that sterilize, and it is molten that 12 μ L citric acids are added
Liquid (50 μ g/mL of final concentration) and 12 μ L various concentration compound 2h solution (final concentration of 10,20,40 μ g/mL), are eventually adding 6 μ
L bacteria suspension (105CFU/mL), level rock mixing after in 30 DEG C of constant incubator cultures for 24 hours.After culture, from each examination
It tests in group to pipette 100 μ L reaction solutions and be diluted to suitable concentration with 10 times of methods and carry out plate coating and count, measurement is added different dense
When spending 2h, bacteriostasis is cooperateed with citric acid.Every group of test is in parallel three times.Blank control group replaces compound with sterile water
2h and citric acid solution.
As seen from Figure 3, citric acid cooperates with bacteriostasis with significant with when 2h compatible use.Concentration is 40 μ g/mL's
The other bacterial concentration of group that inhibitor 2h and citric acid use simultaneously is 0Log10(CFU/mL), illustrate the other bacterial growth of the group
Breeding has been totally constrained.
Experiment 5, the measurement of antioxidant activity
By measurement compound 1c and 2h to the clearance rate of DPPH free radical, hydroxyl radical free radical and ultra-oxygen anion free radical
To evaluate its antioxidant activity.
1, the measurement of DPPH free radical scavenging activity
Bibliography method (Mei-Jia Shi, Xiaoyi Wei, Jie Xu, Bing-Jie Chen, De-Yin Zhao,
Shuai Cui,Tao Zhou.Carboxymethylated Degraded Polysaccharides from
Enteromorpha prolifera:Preparation and in Vitro Antioxidant Activity.Food
Chemistry 2017,215,76-83.) it is measured.
2, the measurement of hydroxyl radical free radical clearance rate
Bibliography method (Mei-Jia Shi, Xiaoyi Wei, Jie Xu, Bing-Jie Chen, De-Yin Zhao,
Shuai Cui,Tao Zhou.Carboxymethylated Degraded Polysaccharides from
Enteromorpha prolifera:Preparation and in Vitro Antioxidant Activity.Food
Chemistry 2017,215,76-83.) it is measured.
3, the measurement of ultra-oxygen anion free radical clearance rate
Bibliography method (Bing-Jie Chen, Mei-Jia Shi, Shuai Cui, Shu-Xian Hao, Robert
C Hider,Tao Zhou.Improved antioxidant and anti-tyrosinase activity of
polysaccharide from Sargassum fusiforme by degradation.International Journal
Of Biological Macromolecules.2016,92,715-722.) it is measured.
Compound 1c and 2h shows good Scavenging activity to three kinds of free radicals, they are to DPPH and hydroxyl radical free radical
Scavenging capacity much stronger than 9b and 9c (table 6).
Free radical scavenging activity (the IC of table 6. compound 1c and 2h50(mg/mL))
Experiment 6, the fresh-keeping experiment of Penaeus Vannmei
Make by taking compound 2h as an example, and with kojic acid and commercially available " the fresh treasured of shrimp " (principle active component 4- hexyl resorcin)
For positive control.The sample pretreatment of Penaeus Vannmei: by fresh and alive prawn (the long 10.5 ± 0.5cm of average body, weight 10.0 ±
It 0.5g) is immersed in 30min in ice water to clean, then be grouped sample at random spare.
The fresh-keeping experiment of Penaeus Vannmei: kojic acid solution (1mg/mL) is prepared respectively, 4- hexyl resorcin solution (1mg/
ML), compound 2h solution (1mg/mL), 1mg/mL compound 2h+0.1% ascorbic acid solution, 1mg/mL compound 2h+
0.1% citric acid solution, using ultrapure water as blank control.Each group shrimp sample is soaked in respectively in 6 kinds of different solutions,
It pulls out to drain to be filled in sterilized antistaling bag after 10min and be stored in 4 DEG C of refrigerators.It measures within (2,4,6,8,10,12 days) in storage phase
The indices of different group shrimp samples.
1, color change measures
The color at each test group difference storage phase shrimp sample carapace is measured using color difference analysis instrument, parallel 3 times.It uses
CIE Lab system indicates the color of sample, L*The brightness of representative sample, range 0-100, numerical value illustrate sample closer to 0
Color is darker, brighter closer to 100;a*The red value of green of representative sample indicates color sample from-a*(green) arrives+a*(red)
Variation;b*The champac value of representative sample indicates color sample from-b*(blue) arrives+b*The variation of (yellow).
By Fig. 4 A it is found that the L of blank group and each processing group*All decline as time increases.The L of blank control group*Under
Drop quickly, its L at the 4th day*Value has dropped to 37.66.The L of treated with kojic acid group*Value starts to be decreased obviously on day 4, the 6th day and
Respectively reach 37.06 and 33.63 within 12nd day.In storage phase, it is 4-HR < 2h < 2h+ that each processing group, which inhibits the ability of shrimp body blacking,
0.1%AA < 2h+0.1%CA, L*Value respectively 36.05,37.03,37.83,38.04, the above results explanation at the 12nd day
Compound 2h has the stronger ability for inhibiting the blacking of shrimp body compared to 4-HR;The addition of ascorbic acid and citric acid then further mentions
The high anti-shrimp body blacking ability of formula, substantially improves the visual experience of shrimp body.
By Fig. 4 B it is found that all groups of a*Value all rises with the increase of storage time, illustrates shrimp body carapace color
Gradually turn red, wherein the variation of blank control group is most obvious, its a at the 4th day*Value has risen to 0.90, hence it is evident that is greater than everywhere
Reason group (P < 0.05).At the 12nd day, a of treated with kojic acid group*Value is 3.23, less than the 4.26 of blank control group, but is far longer than
2.62,2.41,2.13 and the 2.05 of other 4 processing groups.Storage phase 0-12 days, 2h+0.1%AA and 2h+0.1%CA processing group
a*The ascendant trend of value is significantly less than 4-HR, 2h, a of the processing group of 4-HR, 2h at the 12nd day*Value is 2.62 and 2.41, and 2h+
0.1%AA and 2h+0.1%CA processing group is only 2.13 and 2.05.
As shown in Figure 4 C, b*The variation tendency and a of value*It is worth similar, shrimp body all xanthochromias with the extension of time, and 2h+
0.1%AA and 2h+0.1%CA processing group has strongest inhibition shrimp body xanthochromia ability.At the 12nd day, 2h+0.1%AA and 2h+
The b of 0.1%CA processing group*Value is respectively 3.86 and 3.78, is lower than blank control group, treated with kojic acid group, 4-HR and 2h processing group
9.70,6.36,5.18 and 4.26.
2, the measurement of total number of bacteria
GB 4789.2- is referred to the measuring method of the total number of bacteria in the shrimp sample of each test group difference storage time
2016 " Food Microbiology detects total plate count measurement ".Method particularly includes: weigh 5g shrimp in sterile homogenizing bag, then plus
Enter 45mL sterile saline, obtains the even liquid of 1:10 sample after patting 1-2min with sterile homogenizer.Using 10 times of dilution methods, use
The even liquid of sample is diluted to 10 by sterile saline-2、10-3、10-4、10-5、10-6Deng the even liquid of sample.It is a suitable dilute to choose 2-3
The even liquid of sample for releasing concentration draws 100 μ L respectively and adds on the counting solid culture medium of sterilized solidification and be coated, often
A dilution makees two plates, in 37 DEG C of 48 ± 2h of culture.Plate of the clump count within the scope of 30CFU~300CFU is chosen to carry out
It counts, result is the average value of two plates.
The variation of total number of bacteria (Total bacterial count, TBC) of the Penaeus Vannmei sample in storage phase is such as
Shown in Fig. 5, the initial bacterial count of Penaeus Vannmei sample is about 3.24lg (CFU/g), and the TBC of each processing group all with when
Between increase and increase.In storage phase (0-12 days), secondly it is treated with kojic acid group that the TBC increase of blank control group is most fast.2h
The TBC of processing group is significantly less than 4-HR processing group (P < 0.05) in storage phase 8-12 days, illustrates that compound 2h has compared with 4-HR
Stronger bacteriostasis.In 0-12 days, the TBC of 2h and 2h+0.1%AA processing group is without significant difference (P > 0.05).Entirely storing up
Hide interim, the TBC of 2h+0.1%CA processing group is both less than other processing groups.General total number of bacteria reaches 6lg (CFU/g) and is recognized
To reach corrupt limit, blank control group, treated with kojic acid group, 4-HR, 2h and 2h+0.1%AA processing group are respectively at storage phase
6,8,10 and 12 days are more than corrupt limit, and TBC at 2h+0.1%CA processing group the 12nd day is only 5.82, still not up to corruption
Limit shows strong bacteriostasis.
3, the measurement of Volatile Base Nitrogen (TVB-N)
Bibliography method (Chen B J, Zhou Y J, Wei X Y, et al.Edible antimicrobial
coating incorporating a polymeric iron chelator and its application in the
preservation of Surimi product[J].Food&Bioprocess Technology,2016,9(6):1031-
1039.) be measured.
Penaeus Vannmei sample in TVB-N value situation of change in storage phase as shown in fig. 6, each group TVB-N value all with
The increase of time dramatically increases (P < 0.05).Blank control group and the TVB-N value of kojic acid control group were respectively at the 2nd, 4 day Shi Mingxian
Increase, the 8th day when respectively reaches 47.22 and 37.36mg/100g, alreadys exceed national standard GB2733-2015 " food safety country
Standard is fresh, freezes animality aquatic products " specified in the TVB-N values of seawater fishes and shrimps must not exceed the requirement of 30mg/100g.4-HR,
The TVB-N value of 2h, 2h+0.1%AA and 2h+0.1%CA processing group started to occur in storage phase the 8th day significantly to increase (P <
0.05), the 12nd day when 4-HR, 2h, 2h+0.1%AA processing group TVB-N value be more than 30mg/100g, respectively reach 40.09,
37.42,34.16, and the TVB-N value (27.33mg/100g) of 2h+0.1%CA processing group is still below 30mg/100g.
In summary multiple index of fish freshness, the compound of the present invention 2h prevent refrigeration (4 DEG C) South America white right with stronger
The effect of shrimp corruption blacking, and be better than widely used shrimp antistaling agent 4- hexyl resorcin, and by the shelf of Penaeus Vannmei
Phase extends to 10 days.And 2h compatible use 0.1%CA can further extend the shelf life of shrimp to 12 days.
The above list is only a few specific embodiments of the present invention for finally, it should also be noted that.Obviously, this hair
Bright to be not limited to above embodiments, acceptable there are many deformations.Those skilled in the art can be from present disclosure
All deformations for directly exporting or associating, are considered as protection scope of the present invention.
Claims (7)
1. stilbene class similar compound, it is characterized in that general structure is following any:
R in compound1It is following any: 4-OH, 3,4-di-OH, 3,5-di-OH;
R2For CnH2n+1(n=1-12).
2. stilbene class similar compound according to claim 1, it is characterized in that structural formula is following any:
3. the preparation method of stilbene class similar compound as claimed in claim 1 or 2, it is characterized in that:
1), using kojic acid as raw material, quaternary phosphonium salt is reacted to obtain with triphenylphosphine after benzyl protection, chlorination;
2), quaternary phosphonium salt is reacted with benzaldehyde generation wittig;
3), step 2) gains are deprotected through Boron tribromide, obtain the stilbene class similar compound 1 containing free hydroxyl group;
Alternatively, step 2) gains are reacted with the fatty amine of different carbon chain lengths, then it is deprotected containing free through Boron tribromide
The stilbene class similar compound 2 of hydroxyl.
4. the purposes of stilbene class similar compound as claimed in claim 1 or 2, it is characterized in that: being used as tyrosinase inhibitor.
5. the purposes of stilbene class similar compound as claimed in claim 1 or 2, it is characterized in that: being used as antibacterial agent.
6. the purposes of stilbene class similar compound as claimed in claim 1 or 2, it is characterized in that: being used as antioxidant.
7. the purposes of stilbene class similar compound as claimed in claim 1 or 2, it is characterized in that: for the fresh-keeping of food or makeup
Product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811534599.1A CN109608392B (en) | 2018-12-14 | 2018-12-14 | Stilbene similar compound and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811534599.1A CN109608392B (en) | 2018-12-14 | 2018-12-14 | Stilbene similar compound and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109608392A true CN109608392A (en) | 2019-04-12 |
CN109608392B CN109608392B (en) | 2020-08-25 |
Family
ID=66010011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811534599.1A Active CN109608392B (en) | 2018-12-14 | 2018-12-14 | Stilbene similar compound and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109608392B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115010826A (en) * | 2022-06-14 | 2022-09-06 | 浙江工商大学 | Chitosan oligosaccharide-hydroxypyridone conjugate and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106986820A (en) * | 2017-02-24 | 2017-07-28 | 浙江工商大学 | The preparation method and purposes of multi-functional pyridone ketone derivatives and its hydrate |
-
2018
- 2018-12-14 CN CN201811534599.1A patent/CN109608392B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106986820A (en) * | 2017-02-24 | 2017-07-28 | 浙江工商大学 | The preparation method and purposes of multi-functional pyridone ketone derivatives and its hydrate |
Non-Patent Citations (5)
Title |
---|
CHEN YU-HUA等人: "Synthesis of kojic acid-derived copper-chelating apoptosis inducing agents", 《MEDICINAL CHEMISTRY RESEARCH》 * |
CHENG GANG等人: "Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer’s disease", 《BIOORGANIC & MEDICINAL CHEMISTRY》 * |
DONG-FANG LI ET AL: "Design and Synthesis of Hydroxypyridinone L phenylalanine Conjugates as Potential Tyrosinase Inhibitors", 《JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY》 * |
XU PING 等人: "Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants , Aβ1-42 aggregation inhibitors and metal-chelating agents for Alzheimer"s disease", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 * |
宋康康: "抑制剂对酪氨酸酶的效应及其对黑色素生成调控的研究", 《中国博士学位论文全文数据库 基础科学辑》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115010826A (en) * | 2022-06-14 | 2022-09-06 | 浙江工商大学 | Chitosan oligosaccharide-hydroxypyridone conjugate and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN109608392B (en) | 2020-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Antifungal activity and mechanism of cinnamon essential oil loaded into mesoporous silica nanoparticles | |
CN107582459B (en) | A kind of preservative and preparation method thereof containing Fructus Forsythiae | |
CN109700679A (en) | Application of the plant-derived compound preservative of food-grade in cosmetics | |
CN109997856A (en) | A kind of composition of small molecule compound and its application | |
Lakshmi et al. | Anticancer potentials of secondary metabolites from endophytes of Barringtonia acutangula and its molecular characterization | |
CN106986820B (en) | The preparation method and purposes of multi-functional pyridone ketone derivatives and its hydrate | |
CN103374526A (en) | Coccidian oocyst culture preservative fluid and application method thereof | |
CN109608392A (en) | Stilbene class similar compound and its preparation method and application | |
CN110810442B (en) | Rapeseed seed meal composition for inhibiting pathogenicity of ralstonia solanacearum and application thereof | |
CN104529885A (en) | Hyroxy-pyridone derivative with multiple biological activities and usage thereof | |
CN103120200A (en) | Preparation method of water-soluble olive polyphenol with bacteriostatic and preserved activity on meat products | |
CN108913650A (en) | Application of the chitosan selenium in terms of inhibiting pig endometrial epithelial cell total antioxidant capacity reduction caused by F-2 toxin | |
CN105124716A (en) | Method of preparing food preservative through extraction waste liquid of cinnamon oil | |
AU2014270306A1 (en) | Use of a bacterium isolated from the genus pseudoalteromonas, cyclolipopeptides and uses thereof | |
Wali et al. | Effect of ethanol and alkaloid extract of Spirulina platensis against dermatophyte fungi | |
CN103610209B (en) | Natural plant preservative taking rape seed cakes and folium ginkgo as raw materials as well as preparation method and application thereof | |
CN113261642A (en) | Application of oridonin in preparation of food preservative | |
CN116212087B (en) | Rare earth metal-based composite antibacterial absorption pad and preparation method thereof | |
JP6931227B2 (en) | Moisturizer | |
CN110372530A (en) | A kind of compound of the structure of substituted-phenyl containing α and preparation method thereof and elimination agent | |
Ogodo et al. | Principles of applied microbiology and biotechnology: Technique for the screening of antimicrobial herbs | |
CN109820906A (en) | It is a kind of inhibit propionibacterium acnes bacteriostatic agent and its application | |
CN105732601B (en) | Coumarin kind compound of the functional group containing imidazoles and its preparation method and application | |
Ohyama | On the antibacterial action and mechanism of nitrofuran derivatives | |
CN109463402A (en) | A kind of preparation method and application of cinnamomum camphora essential oil quorum-quenching agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |